Omega-3, Autism Spectrum Disorder (ASD)

Recruiting now · Not applicable · Has a placebo group

Conditions studied: ASD

In brief

This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).

Key facts

Study ID

NCT07365553

Run by

China Medical University Hospital

People needed

50

Starts

2022-07-15

Expected to finish

2026-07-31

Last updated by the study team

2026-01-26

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of DSM5 ASD made by child and adolescent psychiatrist
• age 6-17 years-old at the time of enrolment
• no pharmacotherapy or non-pharmacotherapy adjustment within the past 4 weeks,
• Signed informed consent.

You may not qualify if…

• comorbid other psychiatric disorders, including schizophrenia or affective mood disorder (Bipolar and Major Depressive Disorder), or substance use disorder
• comorbid physical disorders, such as thyroid dysfunction, cerebral palsy, coagulation disorders
• currently using omega-3 supplements or probiotics
• allergy to omega-3.

Where it is running

• China Medical University — Taichung, Taichung, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.